The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
Akums and TNAU will collaborate to strengthen research through shared expertise and innovative agricultural solutions, to foster innovation in formulation development
Multiple studies show the combination potential of vedotin antibody-drug conjugates (ADCs) with pembrolizumab, including the first Phase 1 data in thoracic cancers for two first-in-class ADCs
Durable pain relief from a single MM-II injection and its cartilage-protective effects in OA modelsfeatured in two peer-reviewed articles
Tolvaptan is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease
The implementation, spearheaded by Deloitte Consulting, brings together domain expertise and cutting-edge technology
Phytonadione Injectable Emulsion possesses the same type and degree of activity as does naturally-occurring vitamin K
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
The company delivered revenues of Rs. 5,554 crore, representing 10% growth in FY25
This unit will focus on the manufacturing of health and wellness equipment
Subscribe To Our Newsletter & Stay Updated
